Developing pet medications that have superior convenience and therapeutic benefits, thereby delivering improved healthcare to pets and economic returns to our investors and strategic partners.
Velcera Home
About Velcera
Velcera Technology
Velcera Business Development
Investor Relations

  Overview
  News Releases
  Events & Presentations
  Management Profiles
  Corporate Governance
  SEC Filings
  Stock Information
  Investor Contact
COntact Velcera

Dennis Steadman
President and CEO
Phone: 267-757-3600
Fax: 267-757-3601
dsteadman@velcera.com

Matthew C. Hill
Chief Financial Officer
Phone: 267-757-3600
Fax: 267-757-3601
mhill@velcera.com